Logo of nihpaLink to Publisher's site
PMC full text:
JAMA Pediatr. Author manuscript; available in PMC 2013 Nov 22.
Published in final edited form as:
JAMA Pediatr. 2013 Jan; 167(1): 10.1001/jamapediatrics.2013.419.
doi: 10.1001/jamapediatrics.2013.419

Table 4

Proportion of Cases and Costs Identified for the Different Screening Strategies for 75% Adherence to Initial Nonfasting Screening Strategies and 75% or 50% Adherence to 2-Hour OGTT

Screening Strategy and Cutoff Value75% Adherence to Nonfasting Screening and 75% Adherence to 2-Hour OGTT
75% Adherence to Nonfasting Screening and 50% Adherence to 2-Hour OGTT
Cases Identified, %Total Costs (Direct and Indirect), $Cost per Case Identified (Direct and Indirect), $Cases Identified, %Total Costs (Direct and Indirect), $Cost per Case Identified (Direct and Indirect), $
Diabetes mellitus
 2-h OGTT (200 mg/dL)75117 083 907312 2245078 055 938312 224
 HbAlc
  5.5%1994 810 2331011 4101286 053 5411376994
  5.7%1985 855 882915 8881280 083 9731281472
  6.5%1970 931 963756 6831270 134 6941122 267
Dysglycemia (prediabetes and diabetes)
 2-h OGTT (140 mg/dL)75117083 9073905078 055 938390
 Random glucose test
  100 mg/dL3174 820 3786052167 551 971819
  110 mg/dL1761 899 6509171158 938 1521310
 HbAlc
  5.5%2594 405 4969321785 783 7161271
  5.7%1884 637 32911761279 271 6051651
  6.5%470 211 9694458369 654 6986634
 1-h Glucose challenge test
  110 mg/dL3599 818 9377042491 627 052970
  120 mg/dL2588 976 0348991784 398 4501279

Abbreviations: HbA1c hemoglobin Alc; OGTT, oral glucose tolerance test.